Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anna Allavena is active.

Publication


Featured researches published by Anna Allavena.


European Journal of Human Genetics | 2013

A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin

I. Borelli; Marco A. Barberis; Francesca Spina; Guido C. Casalis Cavalchini; Caterina Vivanet; Luisa Balestrino; Monica Micheletti; Anna Allavena; Paola Sala; Carlo Carcassi; Barbara Pasini

Lynch syndrome is an autosomal-dominant hereditary condition predisposing to the development of specific cancers, because of germline mutations in the DNA-mismatch repair (MMR) genes. Large genomic deletions represent a significant fraction of germline mutations, particularly among the MSH2 gene, in which they account for 20% of the mutational spectrum. In this study we analyzed 13 Italian families carrying MSH2 exon 8 deletions, 10 of which of ascertained Sardinian origin. The overrepresentation of Sardinians was unexpected, as families from Sardinia account for a small quota of MMR genes mutation tests performed in our laboratory. The hypothesis that such a result is owing to founder effects in Sardinia was tested by breakpoint junctions sequencing and haplotype analyses. Overall, five different exon eight deletions were identified, two of which recurrent in families, all apparently unrelated, of Sardinian origin (one in eight families, one in two families). The c.1277–1180_1386+2226del3516insCATTCTCTTTGAAAA deletion shares the same haplotype between all families and appears so far restricted to the population of South-West Sardinia, showing the typical features of a founder effect. The three non-Sardinian families showed three different breakpoint junctions and haplotypes, suggesting independent mutational events. This work has useful implications in genetic testing for Lynch syndrome. We developed a quick test for each of the identified deletions: this can be particularly useful in families of Sardinian origin, in which MSH2 exon 8 deletions may represent 50% of the overall mutational spectrum of the four MMR genes causing Lynch syndrome.


Cerebrovascular Diseases | 2005

Juvenile Vertebrobasilar Ischaemic Stroke in a Patient with Camurati-Engelmann Disease

Paolo Cerrato; C. Baima; Mauro Bergui; Maria Grazia Grasso; A. Lentini; C. Azzaro; Giovanni Bosco; Daniele Imperiale; Nicola Migone; Anna Allavena; B. Bergamasco

(652C 1 T; Arg 218Cys) in exon 4 (coding the TGF1 latency-associated peptide). Immunological and coagulation tests (namely protein C and S, homocysteine plasma levels, activated protein C resistance, prothrombin polymorphism, lupus anticoagulant, anticardiolipin antibodies) were unremarkable. Cranial CT showed a dramatic increase in the thickness of the skull bones, particularly in the lower half. Brain MRI revealed multiple small ischaemic lesions involving the cerebellar hemispheres ( fi g. 1 A), the left thalamus and the right occipital region and a T 1 hyperintensity on the course of the intracranial right vertebral artery ( fi g. 1 B). Duplex sonography revealed increased carotid wall thickness and reduced fl ow in both vertebral arteries. Digital subtraction angiography demonstrated that the right vertebral artery was occluded immediately after the origin of the postero-inferior cerebellar artery and the left vertebral artery had a reduced lumen between the origin of the postero-inferior cerebellar artery and the vertebrobasilar junction and furnished a normal basilar artery ( fi g. 1 C). Cranial CT revealed patent intravertebral foramina despite the huge thickness of the skull base bone ( fi g. 1 D). Transthoracic and transoesophageal echocardiography revealed only a slight increase in thickness of the endocardium and in the aortic valve. The patient was treated with low-molecular-weight heparin for 2 weeks followed by ticlopidine. No further ischaemic events occurred.


Human Genetics | 2001

TSC1 and TSC2 deletions differ in size, preference for recombinatorial sequences, and location within the gene.

Lucia Longa; Alessandro Saluto; Silvia Polidoro; Sergio Padovan; Anna Allavena; Caterina Carbonara; Enrico Grosso; Nicola Migone


Familial Cancer | 2014

A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns

I. Borelli; Guido C. Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A. Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini


GIORNALE DELLA ACCADEMIA DI MEDICINA DI TORINO | 2012

Fattori genetici predisponenti al carcinoma della mammella

Barbara Pasini; F Vignolo Lutati; G Casalis Cavalchini; Anna Allavena; Paola Ogliara; Cecilia Bracco


European Journal of Human Genetics | 2006

Mutation analysis of the MSH6 gene in 52 MLH1/MSH2-negative, HNPCC suspect Italian patients

P. Pazienza; Marco A. Barberis; I. Borelli; Silvia Regazzoni; Daniela Giachino; G. Casalis Cavalchini; Anna Allavena; Monica Micheletti; A. Arrigoni; M. Schena; Enrico Grosso; T. Venesio; E. David; Barbara Pasini; Nicola Migone; M. De Marchi

Collaboration


Dive into the Anna Allavena's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge